Response to 13-cis-retinoic acid plus interferon alfa-2a in two patients with therapy-refractory advanced renal cell carcinoma

J Clin Oncol. 1995 Oct;13(10):2679-80. doi: 10.1200/JCO.1995.13.10.2679.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Apoptosis / drug effects
  • Carcinoma, Renal Cell / therapy*
  • Drug Synergism
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Isotretinoin / administration & dosage*
  • Isotretinoin / pharmacology
  • Kidney Neoplasms / therapy*
  • Male
  • Recombinant Proteins

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Isotretinoin